Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. (3'r,4's,5'r)-n-((3r,6s)-6-carbamoyltetrahydro-2h-pyran-3-yl)-6''-chloro-4'-(2-chloro-3-fluoro-4-pyridinyl)-4,4-dimethyl-2''-oxo-1'',2''-dihydrodispiro(cyclohexane-1,2'-pyrrolidine-3',3''-indole)-5'-carboxamide
2. Rolontis
3. Spi-2012
1. 1398568-47-2
2. Ds-3032
3. Mdm2 Inhibitor Ds-3032
4. R3i80tln7s
5. Ds-3032b
6. 2,6-anhydro-5-((((3'r,4's,5'r)-6''-chloro-4'-(2-chloro-3-fluoro-4-pyridinyl)-1'',2''-dihydro-4,4-dimethyl-2''-oxodispiro(cyclohexane-1,2'-pyrrolidine-3',3''-(3h)indol)-5'-yl)carbonyl)amino)-3,4,5-trideoxy-l-erythro-hexonamide
7. L-erythro-hexonamide, 2,6-anhydro-5-((((3'r,4's,5'r)-6''-chloro-4'-(2-chloro-3-fluoro-4-pyridinyl)-1'',2''-dihydro-4,4-dimethyl-2''-oxodispiro(cyclohexane-1,2'-pyrrolidine-3',3''-(3h)indol)-5'-yl)carbonyl)amino)-3,4,5-trideoxy-
8. Milademetan [inn]
9. Unii-r3i80tln7s
10. Milademetan [who-dd]
11. Chembl4292264
12. Schembl12527208
13. Ex-a6155
14. Yfc56847
15. Bdbm50467678
16. Ds3032
17. Nsc800893
18. Db15257
19. Nsc-800893
20. Hy-101266
21. Cs-0021065
22. Q27896170
23. (3'r,4's,5'r)-n-((3r,6s)-6-carbamoyltetrahydro-2h-pyran-3-yl)-6''-chloro-4'-(2-chloro-3-fluoro-4-pyridinyl)-4,4-dimethyl-2''-oxo-1'',2''-dihydrodispiro(cyclohexane-1,2'-pyrrolidine-3',3''-indole)-5'-carboxamide
24. (3'r,4's,5'r)-n-[(3r,6s)-6-carbamoyltetrahydro-2h-pyran-3-yl]-6''-chloro-4'-(2-chloro-3-fluoropyridin-4-yl)-4,4-dimethyl-2''-oxo-1'',2''-dihydrodispiro[cyclohexane-1,2'-pyrrolidine-3',3''-indole]-5'-carboxamide
| Molecular Weight | 618.5 g/mol |
|---|---|
| Molecular Formula | C30H34Cl2FN5O4 |
| XLogP3 | 3.4 |
| Hydrogen Bond Donor Count | 4 |
| Hydrogen Bond Acceptor Count | 7 |
| Rotatable Bond Count | 4 |
| Exact Mass | 617.1971881 g/mol |
| Monoisotopic Mass | 617.1971881 g/mol |
| Topological Polar Surface Area | 135 Ų |
| Heavy Atom Count | 42 |
| Formal Charge | 0 |
| Complexity | 1090 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 5 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
A Milademetan manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Milademetan, including repackagers and relabelers. The FDA regulates Milademetan manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Milademetan API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Milademetan supplier is an individual or a company that provides Milademetan active pharmaceutical ingredient (API) or Milademetan finished formulations upon request. The Milademetan suppliers may include Milademetan API manufacturers, exporters, distributors and traders.
Milademetan Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Milademetan GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Milademetan GMP manufacturer or Milademetan GMP API supplier for your needs.
A Milademetan CoA (Certificate of Analysis) is a formal document that attests to Milademetan's compliance with Milademetan specifications and serves as a tool for batch-level quality control.
Milademetan CoA mostly includes findings from lab analyses of a specific batch. For each Milademetan CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Milademetan may be tested according to a variety of international standards, such as European Pharmacopoeia (Milademetan EP), Milademetan JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Milademetan USP).
LOOKING FOR A SUPPLIER?
